Rakuten Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,360
Closed -$10.2M 523
2025
Q4
$10.2M Sell
29,360
-24,731
-46% -$8.36M 0.03% 159
2025
Q3
$4.93M Buy
+54,091
New +$16.8M 0.02% 249
2025
Q1
$9.16M Buy
+21,198
New +$8.51M 0.04% 118
2024
Q3
$6.89M Buy
13,149
+3,250
+33% +$1.74M 0.04% 86
2024
Q2
$5.3M Buy
9,899
+3,581
+57% +$1.89M 0.03% 81
2024
Q1
$3.28M Buy
6,318
+5,736
+986% +$2.85M 0.02% 81
2023
Q4
$273K Buy
+582
New +$269K ﹤0.01% 86

Other funds holding ELV

Rakuten Investment Management's ELV Position: Q1 2026 in Review

Rakuten Investment Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 29,360 shares — an estimated $10.2M sold.

Rakuten Investment Management first reported a position in ELV in Q4 2023 and held it in 7 quarters. The position peaked at $10.2M in Q4 2025. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Rakuten Investment Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Rakuten Investment Management sold 29,360 Elevance Health shares in Q1 2026, an estimated $10.2M.
  • Rakuten Investment Management first reported a position in Elevance Health in Q4 2023 and held it in 7 quarters.
  • Rakuten Investment Management's Elevance Health position peaked at $10.2M in Q4 2025.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Rakuten Investment Management's 13F filing for Q1 2026, filed 12 May 2026.